Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Podcasts|February 21, 2023
Independent Rx Forum - Preparing for DIR Fee Changes
Ronna Hauser of the National Community Pharmacists Association discusses how pharmacists should prepare for DIR fee changes with guests from NCPA.
Advertisement
On this episode, host Ronna Hauser of the National Community Pharmacists Association (NCPA) discusses how pharmacists should prepare for DIR fee changes with Tripp Logan, PharmD, owner of SEMO Rx Pharmacies and Services, Scott Pace, PharmD, JD, co-owner of Kavanaugh Pharmacy and partner at Impact Management Group, and Doug Hoey, the CEO of NCPA.
Advertisement
Related to this article
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
The approval is supported by findings from the phase 3 OCEANIC-STROKE trial.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Christie Ballantyne, MD, explains how the CORALreef Extension study adds safety exposure and shows LDL-C lowering with oral enlicitide is sustained over time.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
The Most Accessible Healthcare Professional—But Accessible to Whom?
4
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
5